drug class tirzepatide FDA Approves Tirzepatide, A Potential Blockbuster for Type 2 Diabetes Semaglutide vs Tirzepatide for Weight

Serious low blood sugar risk emerges mainly when semaglutide is combined with insulin injections or sulfonylurea drugs, which force constant insulin release regardless of glucose levels

As a GLP-1 receptor agonist component, tirzepatide significantly slows gastric emptying , which is one of the key mechanisms through which it promotes satiety and aids weight loss

Gut Health: It can help repair the gut lining, making it potentially useful for people with digestive issues such as ulcers, irritable bowel syndrome (IBS), and Crohns disease

The FTO variant (rs9939609) reveals genetic predisposition to weight gain and appetite regulation, while the MC4R variant (rs17782313) controls melanocortin-4 receptor function in appetite and energy expenditure

By application, the obesity management segment led with a market share of 60% in 2024